Globus Medical, Inc. - stock earnings
GMED Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 15.0 million USD | 616.5 million USD |
| 2023Q3 | 998000 USD | 383.6 million USD |
| 2023Q2 | 57.7 million USD | 291.6 million USD |
| 2023Q1 | 49.1 million USD | 276.7 million USD |
| 2022Q4 | 50.1 million USD | 274.5 million USD |
| 2022Q3 | 47.4 million USD | 254.1 million USD |
| 2022Q2 | 54.6 million USD | 263.6 million USD |
| 2022Q1 | 38.1 million USD | 230.5 million USD |
| 2021Q4 | 15.1 million USD | 250.0 million USD |
| 2021Q3 | 47.2 million USD | 229.7 million USD |
| 2021Q2 | 41.5 million USD | 251.0 million USD |
| 2021Q1 | 45.3 million USD | 227.3 million USD |
| 2020Q4 | 53.0 million USD | 233.4 million USD |
| 2020Q3 | 44.2 million USD | 216.1 million USD |
| 2020Q2 | -20.8 million USD | 148.9 million USD |
| 2020Q1 | 25.9 million USD | 190.6 million USD |
| 2019Q4 | 45.5 million USD | 211.7 million USD |
| 2019Q3 | 38.3 million USD | 196.2 million USD |
| 2019Q2 | 38.2 million USD | 194.5 million USD |
| 2019Q1 | 33.2 million USD | 182.9 million USD |
| 2018Q4 | 36.8 million USD | 195.9 million USD |
| 2018Q3 | 35.2 million USD | 169.2 million USD |
| 2018Q2 | 45.0 million USD | 173.4 million USD |
| 2018Q1 | 39.5 million USD | 174.4 million USD |
| 2017Q4 | 24.4 million USD | 176.0 million USD |
| 2017Q3 | 25.6 million USD | 151.7 million USD |
| 2017Q2 | 28.7 million USD | 152.4 million USD |
| 2017Q1 | 28.7 million USD | 155.8 million USD |
| 2016Q4 | 24.3 million USD | 151.6 million USD |
| 2016Q3 | 26.2 million USD | 135.7 million USD |
| 2016Q2 | 25.8 million USD | 137.5 million USD |
| 2016Q1 | 28.0 million USD | 139.3 million USD |
| 2015Q4 | 37.6 million USD | 142.6 million USD |
| 2015Q3 | 26.5 million USD | 137.0 million USD |
| 2015Q2 | 24.1 million USD | 133.6 million USD |
| 2015Q1 | 24.6 million USD | 131.6 million USD |
| 2014Q4 | 27.6 million USD | 128.8 million USD |
| 2014Q3 | 23.1 million USD | 117.8 million USD |
| 2014Q2 | 20.6 million USD | 113.6 million USD |
| 2014Q1 | 21.1 million USD | 114.2 million USD |
| 2013Q4 | 21.0 million USD | 115.2 million USD |
| 2013Q3 | 20.3 million USD | 107.2 million USD |
| 2013Q2 | 7.4 million USD | 107.0 million USD |
| 2013Q1 | 19.9 million USD | 105.0 million USD |
| 2012Q4 | 20.8 million USD | 100.5 million USD |
| 2012Q3 | 16.5 million USD | 94.8 million USD |
| 2012Q2 | 19.0 million USD | 96.0 million USD |
| 2012Q1 | 17.6 million USD | 94.7 million USD |
| 2011Q4 | 13.6 million USD | 88.0 million USD |
| 2011Q3 | 16.9 million USD | 84.3 million USD |
| 2011Q2 | 15.9 million USD | 80.9 million USD |
| 2011Q1 | 14.4 million USD | 78.3 million USD |
| 2010Q4 | 54.5 million USD | 288.2 million USD |
GMED Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 122.9 million USD | 1.6 billion USD |
| 2022 | 190.2 million USD | 1.0 billion USD |
| 2021 | 149.2 million USD | 958.1 million USD |
| 2020 | 102.3 million USD | 789.0 million USD |
| 2019 | 155.2 million USD | 785.4 million USD |
| 2018 | 156.5 million USD | 713.0 million USD |
| 2017 | 107.3 million USD | 636.0 million USD |
| 2016 | 104.3 million USD | 564.0 million USD |
| 2015 | 112.8 million USD | 544.8 million USD |
| 2014 | 92.5 million USD | 474.4 million USD |
| 2013 | 68.6 million USD | 434.5 million USD |
| 2012 | 73.8 million USD | 386.0 million USD |
| 2011 | 60.8 million USD | 331.5 million USD |
| 2010 | 54.5 million USD | 288.2 million USD |
| 2009 | 48.7 million USD | 254.3 million USD |
GMED
Price: $49.79
52 week price:
Earnings Per Share: 1.07 USD
P/E Ratio: 35.62
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 237483
Ebitda: 46.6 millionMarket Capitalization: 7.3 billion